HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


St. John's Wort, Rx Drug Use Warning Adopted By CHPA

This article was originally published in The Tan Sheet

Executive Summary

Consumer Healthcare Products Association member companies soon will be incorporating a prescription drug use warning on their St. John's wort supplements.

You may also be interested in...

CHPA Kava Voluntary Warning Advises Against Driving

The Consumer Healthcare Products Association has adopted a voluntary program for member companies producing kava kava supplements to include a label warning about the botanical's ability to induce drowsiness.

AHPA St. John's Wort, Saw Palmetto Labeling Guidances Issued

Guidances recommending cautionary statements on the labeling of St. John's wort and saw palmetto products were adopted recently by the American Herbal Products Association's Board of Trustees.

Supplement/Warfarin Interactions Reviewed In AJHP Article

Numerous dietary supplements, including coenzyme Q10 and dong quai, may cause adverse events due to possible interactions with the Rx anticoagulant warfarin, an article in the July 1 American Journal of Health-System Pharmacy notes.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts